245 related articles for article (PubMed ID: 28800068)
1. Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.
Trimboli P; Virili C; Romanelli F; Crescenzi A; Giovanella L
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800068
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples.
Mohan U; Sunny SP; Mendonca P; Kuriakose MA; Kannan S; Suresh A
Endocr Pathol; 2022 Jun; 33(2):243-256. PubMed ID: 35596875
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
Kim MJ; Kim HJ; Hong SJ; Shong YK; Gong G
Acta Cytol; 2006; 50(1):28-34. PubMed ID: 16514837
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: validation of molecular markers and technology innovation.
Papale F; Cafiero G; Grimaldi A; Marino G; Rosso F; Mian C; Barollo S; Pennelli G; Sorrenti S; De Antoni E; Barbarisi A
J Cell Physiol; 2013 May; 228(5):968-74. PubMed ID: 23042505
[TBL] [Abstract][Full Text] [Related]
5. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.
Sapio MR; Guerra A; Posca D; Limone PP; Deandrea M; Motta M; Troncone G; Caleo A; Vallefuoco P; Rossi G; Fenzi G; Vitale M
Endocr Relat Cancer; 2007 Dec; 14(4):1089-97. PubMed ID: 18045960
[TBL] [Abstract][Full Text] [Related]
7. Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1.
Rago T; Scutari M; Loiacono V; Santini F; Tonacchera M; Torregrossa L; Giannini R; Borrelli N; Proietti A; Basolo F; Miccoli P; Piaggi P; Latrofa F; Vitti P
Thyroid; 2017 Jan; 27(1):103-110. PubMed ID: 27809694
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
[TBL] [Abstract][Full Text] [Related]
9. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
Hooft L; van der Veldt AA; Hoekstra OS; Boers M; Molthoff CF; van Diest PJ
Clin Endocrinol (Oxf); 2008 Feb; 68(2):252-7. PubMed ID: 17868400
[TBL] [Abstract][Full Text] [Related]
10. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
12. Can galectin-3 be a useful marker for conventional papillary thyroid microcarcinoma?
Gweon HM; Kim JA; Youk JH; Hong SW; Lim BJ; Yoon SO; Park YM; Son EJ
Diagn Cytopathol; 2016 Feb; 44(2):103-7. PubMed ID: 26681546
[TBL] [Abstract][Full Text] [Related]
13. Use and accuracy of fine-needle aspiration cytology in histologically proven thyroid carcinoma: an audit using a national nathology database.
Giard RW; Hermans J
Cancer; 2000 Dec; 90(6):330-4. PubMed ID: 11156515
[TBL] [Abstract][Full Text] [Related]
14. Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules.
Sciacchitano S; Lavra L; Ulivieri A; Magi F; Porcelli T; Amendola S; De Francesco GP; Bellotti C; Trovato MC; Salehi LB; Bartolazzi A
Endocrine; 2016 Oct; 54(1):139-147. PubMed ID: 26475496
[TBL] [Abstract][Full Text] [Related]
15. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
[TBL] [Abstract][Full Text] [Related]
16. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis.
Trimboli P; Treglia G; Guidobaldi L; Romanelli F; Nigri G; Valabrega S; Sadeghi R; Crescenzi A; Faquin WC; Bongiovanni M; Giovanella L
Clin Endocrinol (Oxf); 2015 Feb; 82(2):280-5. PubMed ID: 25047365
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
Matesa N; Samija I; Kusić Z
Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous large-needle aspiration biopsy histology of palpable thyroid nodules: technical and diagnostic performance.
Carpi A; Nicolini A; Marchetti C; Iervasi G; Antonelli A; Carpi F
Histopathology; 2007 Aug; 51(2):249-57. PubMed ID: 17650219
[TBL] [Abstract][Full Text] [Related]
19. Role of pro-angiogenic marker galectin-3 in follicular neoplasms of thyroid.
Manivannan P; Siddaraju N; Jatiya L; Verma SK
Indian J Biochem Biophys; 2012 Oct; 49(5):392-4. PubMed ID: 23259327
[TBL] [Abstract][Full Text] [Related]
20. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
